Regulation of DDAH1 as a Potential Therapeutic Target for Treating Cardiovascular Diseases

Asymmetric dimethylarginine (ADMA) is an endogenous nitric oxide synthase inhibitor that blocks nitric oxide production, while congestive heart failure is associated with increased plasma and tissue ADMA content. Increased plasma ADMA is a strong and independent predictor of all-cause mortality in t...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xiaoyu, Fassett, John, Wei, Yidong, Chen, Yingjie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3710625/
https://www.ncbi.nlm.nih.gov/pubmed/23878601
http://dx.doi.org/10.1155/2013/619207

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3710625/
https://www.ncbi.nlm.nih.gov/pubmed/23878601
http://dx.doi.org/10.1155/2013/619207

Ejemplares similares